NanoKnife series published in EUO

Recently European Urology Oncology accepted the publication of the largest focal NanoKnife therapy group in the world.

The article: Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Eur Urol Oncol (2019), looked at 123 patients all with MRI followup and biopsy followup with a minimum of one year follow up. This series showed a 97% clearance of cancer infield and a 10% to 12% chance of recurrence in the outfield. This is part of the 300 cases performed by Professor Stricker to date.